Wall Street Analysts See a 208.52% Upside in 4D Molecular Therapeutics (FDMT): Can the Stock Really Move This High?

4D Molecular Therapeutics, Inc. (FDMT) closed the last trading session at $10.09, gaining 42.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 31.13 indicates a 208.5% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $8.37. While the lowest estimate of$ 16.00 indicates a 58.6% increase from the current price level, the most ...